Patient documents – ToxiTEN – grand public
Marie Guillou2020-10-16T14:37:12+02:00Severe cutaneous drug reactions (ToxiTEN) Patient documents SJS / TEN Patient Information LeafletRecommended by the ERN-Skin2019 [...]
About Marie Guillou
This author has not yet filled in any details.So far Marie Guillou has created 114 blog entries.
Patient documents – Mosaic – grand public
Marie Guillou2020-10-08T16:30:56+02:00Cutaneous Mosaic Disorders : Naevi & Naevoid skin disorders – Complex vascular malformations and cutaneous and subcutaneous vascular tumors Patient documents [...]
Patient documents – MCTD – grand public
Marie Guillou2020-10-08T16:31:04+02:00Mendelian connective tissue disorders Patient documents
Patient documents – IPK – grand public
Marie Guillou2020-10-08T16:31:14+02:00Ichthyosis and Palmoplantar Keratoderma Patient documents
Patient documents – ED – grand public
Marie Guillou2020-10-08T16:56:08+02:00Ectodermal Dysplasias including Incontinentia Pigmenti and p63-associated disorders Patient documents Everybody's Different Elaborated by the ERN-Skin 2019 [...]
Patient documents – EB – grand public
Marie Guillou2020-10-08T16:31:23+02:00Inherited Epidermolysis Bullosa and skin fragility syndromes – Darier disease – Hailey-Hailey disease Patient documents [...]
Patient documents – DNA – grand public
Marie Guillou2020-10-08T17:06:18+02:00Cutaneous diseases related to DNA repair disorders Patient documents Patient Pathway - Xeroderma Pigmentosum Elaborated by the ERN-Skin 2020 [...]
Patient documents – ALLOCATE – grand public
Marie Guillou2020-10-19T13:53:43+02:00Acquired immunologicaL LOw prevalence and Complex AdulT diseases of thE SKIN Patient documents European patient organisations Elaborated by the ERN-Skin 2020 [...]
Patient documents – AIBD – grand public
Marie Guillou2020-10-08T17:22:44+02:00Autoimmune Bullous diseases Patient documents AIBD VADEMECUM english Elaborated by the ERN-Skin 2020 Drugs used in Autoimmune bullous disease Elaborated by [...]
Clinical OutCome Measures – ToxiTEN
Marie Guillou2020-09-28T17:30:25+02:00Severe cutaneous drug reactions (ToxiTEN) Clinical OutCome Measures